Table 5.

Multiple linear regression to identify associations with posttraumatic growth

Characteristic	PTGI adjusted for PCL-C
	Bivariate association (n=886)			Multivariate association (n=762)
	Coefficient, β	SE	P	Coefficient, β	SE	P
PCL-C	0.06	0.09	.467	−0.06	0.10	.535
Demographic characteristics
Female gender	6.27	1.67	<.001	6.74	1.63	<.001
Non-Caucasian race	11.55	2.38	<.001	10.55	2.50	<.001
Income < $30,000	4.63	1.93	.016	1.96	2.04	.338
Less than college degree	7.19	1.70	<.001	5.56	1.76	.002
Age at study enrollment	−0.15	0.06	.019	−0.14	0.07	.031
Clinical characteristics
Years since diagnosis	0.23	0.12	.046	0.12	0.12	.312
Stage >1 at diagnosis	8.42	1.69	<.001	6.56	1.75	<.001
Aggressive lymphoma type	4.74	1.73	.006	1.64	1.75	.350
Not currently receiving treatment	7.12	2.50	.004	5.84	2.42	.016
Ever received chemotherapy	9.07	2.04	<.001	0.56	2.27	.805
Ever received a transplant	4.32	2.33	.064	−1.58	2.42	.515
Co-morbidity score1	0.03	0.17	.878	0.11	0.18	.564
Psychosocial status
Social Support2	0.32	0.05	<.001	0.35	0.05	<.001
ALTTIQ3	1.10	0.14	<.001	0.83	0.16	<.001
Model-adjusted R2		N/A			0.20

¹Self-administered Co-morbidity Questionnaire; possible range, 0–45; higher scores indicate more comorbidities.

²Medical Outcomes Study Social Support total score; possible range, 0–100; higher scores indicate higher support.

³Appraisal of Life Threat and Treatment Intensity total score; possible range, 0–35; higher scores indicate more negative appraisals.